Neurological Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Proteomics Genomics Imaging Bioinformatics Others Segment by Application Diagnostics Drug Discovery Personalized Medicine Others By Company Thermo Fisher Scientific Merck Quest Diagnostics Abbott Roche Illumina Bio-Rad Laboratories QIAGEN Myriad RBM Cisbio Bioassays Athena Diagnostics BGI Wuxi APP Aepodia Proteome Sciences Genewiz By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 Neurological Biomarkers Product Introduction 1.2 Market by Type 1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type 1.4.2 Proteomics 1.4.3 Genomics 1.2.4 Imaging 1.2.5 Bioinformatics 1.2.6 Others 1.3 Market by Application 1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Applicat
